Search results
Results From The WOW.Com Content Network
www.bpjs-kesehatan.go.id. Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan, lit. 'Social Security Agency on Health') is a social security agency of Indonesia aimed at providing universal health care to its citizens. [1] BPJS Kesehatan is one of two social security agencies in the country alongside BPJS Ketenagakerjaan [ id] .
Jalan H.R. Rasuna Said Blok X.5 Kav. 4-9. Jakarta Selatan 12950. Jakarta, Indonesia. Minister responsible. Budi Gunadi Sadikin, Minister of Health. Website. www .kemkes .go .id. Former logo of the Ministry of Health, used until 14 November 2016. The Ministry of Health ( Indonesian: Kementerian Kesehatan) is a government ministry which organize ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The Research Organization for Health ( Indonesian: Organisasi Riset Kesehatan, OR Kesehatan) is one of Research Organizations under the umbrella of the National Research and Innovation Agency ( Badan Riset dan Inovasi Nasional, BRIN). The organization is transformation of National Institute of Health Research and Development ( Badan Penelitian ...
2024 gross margin: About 40.3% (previous: about 39.3% vs. 38.8% a year ago) Trading on a trailing 12-month price-to-sales ratio of only 0.5x, some would argue Gap is a value stock. But is it?
The therapy carries a price tag of $3.5 million in the U.S. - the same as Australian drugmaker CSL Ltd's rival gene therapy Hemgenix. In the EU, it will be sold under the brand name Durveqtix.
Travis Kelce loves The Tortured Poets Department just like the rest of us. Kelce, 34, was asked to rank his top three songs by his superstar girlfriend, Taylor Swift, at his second annual Kelce ...
3 Body Problem is an American science fiction television series created by David Benioff, D. B. Weiss and Alexander Woo, based on the Hugo Award –winning Chinese novel series Remembrance of Earth's Past by Liu Cixin. It is the second live-action adaptation after the 2023 Chinese television series .